US Stock MarketDetailed Quotes

ALNY Alnylam Pharmaceuticals

Watchlist
  • 151.370
  • -0.920-0.60%
Close May 9 16:00 ET
19.15BMarket Cap-57337P/E (TTM)

Alnylam Pharmaceuticals Key Stats

Alnylam Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 2, 2024

Revenue(YoY)

494.33M

+54.82%
EPS(YoY)

-0.52

+62.86%

Buy

May 9, 2024

Alnylam Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 22 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 459.212M--
--2024/Q2-- / 444.755M--
May 2, 20242024/Q1494.333M / 426.802M--
Feb 15, 20242023/Q4439.718M / 442.296M--
Nov 2, 20232023/Q3750.530M / 394.549M--
Aug 3, 20232023/Q2318.754M / 350.571M--
May 4, 20232023/Q1319.290M / 312.535M--
Feb 23, 20232022/Q4335.035M / 312.450M--
Oct 27, 20222022/Q3264.306M / 291.658M--
Jul 28, 20222022/Q2224.818M / 256.058M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 459.212M--
--2024/Q2-- / 444.755M--
May 2, 20242024/Q1494.333M / 426.802M--
Feb 15, 20242023/Q4439.718M / 442.296M--
Nov 2, 20232023/Q3750.530M / 394.549M--
Aug 3, 20232023/Q2318.754M / 350.571M--
May 4, 20232023/Q1319.290M / 312.535M--
Feb 23, 20232022/Q4335.035M / 312.450M--
Oct 27, 20222022/Q3264.306M / 291.658M--
Jul 28, 20222022/Q2224.818M / 256.058M--

Unlock Free Earnings Estimates

Alnylam Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 9, 2024

Buy

  • Buy

    59.09%
  • Hold

    40.91%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg